Which are the causes of Schimke Immuno-Osseous Dysplasia?

TL;DR: Schimke Immuno-Osseous Dysplasia (SIOD) is a rare genetic disorder caused by mutations in the SMARCAL1 gene, which is responsible for maintaining the stability of DNA during replication. This condition is inherited in an autosomal recessive pattern, meaning an individual must inherit two copies of the mutated gene—one from each parent—to develop the disease.

What causes Schimke Immuno-Osseous Dysplasia?

The primary cause of Schimke Immuno-Osseous Dysplasia is a defect in the SMARCAL1 gene, located on chromosome 2. This gene provides instructions for creating a protein that acts like a "molecular repair crew," ensuring that DNA remains stable when cells divide. When this gene is mutated, the cellular repair mechanism fails, leading to the systemic issues seen in Schimke Immuno-Osseous Dysplasia patients, including growth failure, immune deficiency, and renal dysfunction.

Is Schimke Immuno-Osseous Dysplasia hereditary?

Yes, Schimke Immuno-Osseous Dysplasia follows an autosomal recessive inheritance pattern. This means that if both parents are asymptomatic carriers of the SMARCAL1 mutation, there is a 25% chance with each pregnancy that their child will be born with the condition. Because it is a genetic condition, there are no known environmental triggers or lifestyle factors that cause the disease; it is present from the moment of conception.

How does the genetic mutation affect the body?

The pathophysiology of Schimke Immuno-Osseous Dysplasia involves several critical biological systems due to the widespread role of the SMARCAL1 protein:

• Skeletal System: Leads to spondyloepiphyseal dysplasia, resulting in short stature.


• Immune System: Causes T-cell deficiency, increasing susceptibility to severe infections.


• Renal System: Frequently causes progressive kidney failure, which is a major clinical focus for patients.


• Vascular System: Can lead to premature atherosclerosis and cerebral ischemia.

Is the etiology fully understood?

While we know that SMARCAL1 mutations cause Schimke Immuno-Osseous Dysplasia, researchers are still investigating exactly how these mutations lead to the wide variation in disease severity observed in the 4 members currently mapped within the DiseaseMaps.org community and global clinical cohorts. Current research focuses on how chromatin remodeling and DNA stress responses contribute to the specific clinical manifestations of Schimke Immuno-Osseous Dysplasia.

Next steps

• Consult a clinical geneticist to confirm the diagnosis through molecular genetic testing of the SMARCAL1 gene.


• Coordinate care with a multidisciplinary team, including a nephrologist, immunologist, and endocrinologist.


• Connect with others via DiseaseMaps.org to share experiences with the 4 community members currently navigating life with Schimke Immuno-Osseous Dysplasia.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Schimke immuno-osseous dysplasia.


• Orphanet: Schimke immuno-osseous dysplasia (ORPHA:3153).


• OMIM (Online Mendelian Inheritance in Man): #242900 - Schimke immuno-osseous dysplasia.


• National Center for Biotechnology Information (NCBI) Gene: SMARCAL1 protein function.